Showing results (81-90 of 124) with videos related to

Sort By:
Pageof 13
Cartilage|November 8, 2017
Decision Algorithms for the Retreatment with Viscosupplementation in Patients Suffering from Knee Osteoarthritis: Recommendations from the EUROpean VIScosupplementation COnsensus Group (EUROVISCO)Raghu Raman, Yves Henrotin, Xavier Chevalier, et al.
BMC Complementary and Alternative Medicine|June 3, 2014
Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trialYves Henrotin, Myriam Gharbi, Yvan Dierckxsens, et al.
Cartilage|November 29, 2022
EUROVISCO Good Practice Recommendations for a First Viscosupplementation in Patients with Knee OsteoarthritisThierry Conrozier, Demirhan Diraçoglù, Jordi Monfort, et al.
Frontiers in Pharmacology|August 29, 2022
Curcuma longa and Boswellia serrata Extracts Modulate Different and Complementary Pathways on Human Chondrocytes In Vitro: Deciphering of a Transcriptomic StudyChristelle Sanchez, Jérémie Zappia, Cécile Lambert, et al.
Cartilage|October 22, 2019
Serum Levels of Coll2-1, a Specific Biomarker of Cartilage Degradation, Are Not Affected by Sampling Conditions, Circadian Rhythm, and SeasonalityAnne-Christine Hick, Misch Fonck, Bérénice Costes, et al.
BMC Musculoskeletal Disorders|July 7, 2022
Rubus idaeus extract improves symptoms in knee osteoarthritis patients: results from a phase II double-blind randomized controlled trialYves Henrotin, Romain Le Cozannet, Pascale Fança-Berthon, et al.
Journal of Clinical Medicine|June 20, 2019
Parathyroid Hormone-Related Protein (PTHrP) Accelerates Soluble RANKL Signals for Downregulation of Osteogenesis of Bone Mesenchymal Stem CellsJeevithan Elango, Saeed Ur Rahman, Yves Henrotin, et al.
Osteoarthritis and Cartilage|February 25, 2005
New serum biochemical markers (Coll 2-1 and Coll 2-1 NO2) for studying oxidative-related type II collagen network degradation in patients with osteoarthritis and rheumatoid arthritisMichelle Deberg, Alain Labasse, Stephan Christgau, et al.
Therapeutic Advances in Musculoskeletal Disease|June 9, 2021
Viscosupplementation for the treatment of osteoarthritis. The contribution of EUROVISCO groupThierry Conrozier, Raghu Raman, Xavier Chevalier, et al.
Cartilage|June 22, 2018
EUROVISCO Recommendations for Optimizing the Clinical Results of Viscosupplementation in OsteoarthritisThierry Conrozier, Jordi Monfort, Xavier Chevalier, et al.
Pageof 13